BOSTON--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced that its Board of Directors has authorized the Company to repurchase up to ten million shares of its own common stock over the next four years. Purchases will be made through open market transactions or privately negotiated transactions, subject to market conditions and trading restrictions.
